United Guardian (UG) Cash from Operations Growth (1y) (2011 - 2026)
Powered by 
Analysis
United Guardian (UG) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn | 122.18% |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn | -33.32% |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn | 63.07% |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn | -11.73% |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | 243.47% |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn | 107.90% |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn | 1,034.67% |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | 63.59% |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn | 401.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 401.25% |
| Mar 31, 2026 | 87.70% |
| Dec 31, 2025 | 22.73% |
| Sep 30, 2025 | -17.72% |
| Jun 30, 2025 | -77.10% |
| Mar 31, 2025 | -50.00% |
| Dec 31, 2024 | -76.12% |
| Sep 30, 2024 | 5.50% |
| Jun 30, 2024 | 204.64% |
| Mar 31, 2024 | 54.25% |
| Dec 31, 2023 | 80.49% |
| Sep 30, 2023 | 58.27% |
| Jun 30, 2023 | -61.78% |
| Mar 31, 2023 | 1,423.21% |
| Dec 31, 2022 | -62.47% |
| Sep 30, 2022 | -28.66% |
| Jun 30, 2022 | -30.11% |
| Mar 31, 2022 | -97.23% |
| Dec 31, 2021 | 147.50% |
| Sep 30, 2021 | 494.02% |